About this trial
Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions
Eligibility criteria
Qualifiers
Healthy male or female volunteers aged 18 to 64 years (inclusive).
Informed consent form signed voluntarily before any study-related procedure.
Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions.
Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas).
Disqualifiers
Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices.
History of keloid formation, hypertrophic scarring, or abnormal wound healing.
Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities.
History of diabetes mellitus, peripheral vascular disease, or arterial/venous microangiopathy.
Trial design
Treatments tested in this trial
- hydrogel plaster with dexpanthenol
- Standard plaster
Treatment groups
Sponsors and collaborators
Wooshin Labottach Co., Ltd.
Lead sponsor
Nextrasearch S.r.l.s.
Collaborator